DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
PF-06305591 is an investigational drug.
There have been 4 clinical trials for PF-06305591. The most recent clinical trial was a Phase 1 trial, which was initiated on April 1st 2013.
The most common disease condition in clinical trials is [disabled in preview]. The leading clinical trial sponsors are Pfizer and [disabled in preview].
There is one US patent protecting this investigational drug and nine international patents.
Recent Clinical Trials for PF-06305591
|Cold Pressor Test is Used in This Study to Assess the Effect of PF-06305591 on Pain Intensity Evoked by Cold in Healthy Male Subjects||Pfizer||Phase 1|
|Safety and Tolerability Study of Multiple Doses of PF-06305591||Pfizer||Phase 1|
|Effect Of PF-06305591 On Capsaicin And Capsaicin/Heat-Induced Neurogenic Flare||Pfizer||Phase 1|
Top disease conditions for PF-06305591
Top clinical trial sponsors for PF-06305591
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|PF-06305591||European Patent Office||2809655||2032-02-03||Start Trial|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|